Page last updated: 2024-11-03

promethazine and Cancer of Ovary

promethazine has been researched along with Cancer of Ovary in 2 studies

Promethazine: A phenothiazine derivative with histamine H1-blocking, antimuscarinic, and sedative properties. It is used as an antiallergic, in pruritus, for motion sickness and sedation, and also in animals.
promethazine : A tertiary amine that is a substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropan-2-amine moiety.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inbar, M1
Merimsky, O1
Chaitchik, S1
Tsavaris, N1
Polyzos, A1
Kosmas, C1
Giannikos, L1
Gogas, J1

Trials

1 trial available for promethazine and Cancer of Ovary

ArticleYear
A feasibility study of 1-h paclitaxel infusion in patients with solid tumors.
    Cancer chemotherapy and pharmacology, 1997, Volume: 40, Issue:4

    Topics: Aged; Antineoplastic Agents, Phytogenic; Bone Marrow; Breast Neoplasms; Carcinoma, Non-Small-Cell Lu

1997

Other Studies

1 other study available for promethazine and Cancer of Ovary

ArticleYear
Carboplatin-related idiosyncrasy.
    Anti-cancer drugs, 1995, Volume: 6, Issue:6

    Topics: Adenocarcinoma; Anti-Allergic Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Cisplatin; Dr

1995